May 2. The prescribing information for Enbrel (etabercept) is revised to include a boxed warning about infections. MedWatch Safety Information
April 29. FDA approves Amitiza (lubiprostone) for the treatment of irritable bowel syndrome with constipation in adult women aged 18 and over. FDA News
April 28. Actavis Totowa LLC recalls all strengths of Digitek (digoxin tablets, USP), a drug used to treat heart failure and abnormal heart rhythms. MedWatch Safety Information
April 25. FDA updates information to healthcare facilities and healthcare professionals about heparin and heparin-containing medical products. Information
April 25. FDA approves Relistor (methylnaltrexone bromide) for opioid-induced constipation. FDA News
